FDA Approved: CLONAZEPAM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for clonazepam from Aurobindo Pharma Limited under an ANDA, confirming continued availability of this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Absence Seizures
• Epilepsy
• Lennox-gastaut Syndrome
• Myoclonic Seizures
• Panic Disorder

Drugs mentioned

• Clonazepam (Clonazepam)

Snippet

SUPPL AP for CLONAZEPAM (CLONAZEPAM)